| Literature DB >> 24668879 |
Alice F Goodwin1, Snehlata Oberoi, Maya Landan, Cyril Charles, Jessica C Massie, Cecilia Fairley, Katherine A Rauen, Ophir D Klein.
Abstract
Costello syndrome (CS) is a RASopathy characterized by a wide range of cardiac, musculoskeletal, dermatological, and developmental abnormalities. The RASopathies are defined as a group of syndromes caused by activated Ras/mitogen-activated protein kinase (MAPK) signaling. Specifically, CS is caused by activating mutations in HRAS. Although receptor tyrosine kinase (RTK) signaling, which is upstream of Ras/MAPK, is known to play a critical role in craniofacial and dental development, the craniofacial and dental features of CS have not been systematically defined in a large group of individuals. In order to address this gap in our understanding and fully characterize the CS phenotype, we evaluated the craniofacial and dental phenotype in a large cohort (n = 41) of CS individuals. We confirmed that the craniofacial features common in CS include macrocephaly, bitemporal narrowing, convex facial profile, full cheeks, and large mouth. Additionally, CS patients have a characteristic dental phenotype that includes malocclusion with anterior open bite and posterior crossbite, enamel hypo-mineralization, delayed tooth development and eruption, gingival hyperplasia, thickening of the alveolar ridge, and high palate. Comparison of the craniofacial and dental phenotype in CS with other RASopathies, such as cardio-facio-cutaneous syndrome (CFC), provides insight into the complexities of Ras/MAPK signaling in human craniofacial and dental development.Entities:
Keywords: CS; Costello syndrome; MAPK pathway; RASopathy; Ras; craniofacial development; enamel; gingival hyperplasia; malocclusion; occlusion; receptor tyrosine kinase; signal transduction; tooth development
Mesh:
Substances:
Year: 2014 PMID: 24668879 PMCID: PMC4115793 DOI: 10.1002/ajmg.a.36475
Source DB: PubMed Journal: Am J Med Genet A ISSN: 1552-4825 Impact factor: 2.802